N-methyl-N'-(azide-PEG3)-Cy3
Code | Size | Price |
---|
TAR-T18444-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T18444-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
N-methyl-N'-(azide-PEG3)-Cy3 is a PEG-based linker compound designed for use in the synthesis of PROTACs[1].
CAS:
T18444
Molecular Weight:
580.16
Purity:
0.98
SMILES:
CC(C1=C(N/2C)C=CC=C1)(C)C2=C/C=C/C3=[N+](CCOCCOCCOCCN=[N+]=[N-])C4=C(C=CC=C4)C3(C)C.[Cl-]
References
An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.